Cargando…
Intermetastatic and Intrametastatic Heterogeneity Shapes Adaptive Therapy Cycling Dynamics
Adaptive therapies that alternate between drug applications and drug-free vacations can exploit competition between sensitive and resistant cells to maximize the time to progression. However, optimal dosing schedules depend on the properties of metastases, which are often not directly measurable in...
Autores principales: | Gallaher, Jill, Strobl, Maximilian, West, Jeffrey, Gatenby, Robert, Zhang, Jingsong, Robertson-Tessi, Mark, Anderson, Alexander R.A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10425736/ https://www.ncbi.nlm.nih.gov/pubmed/37205789 http://dx.doi.org/10.1158/0008-5472.CAN-22-2558 |
Ejemplares similares
-
Spatial structure impacts adaptive therapy by shaping intra-tumoral competition
por: Strobl, Maximilian A. R., et al.
Publicado: (2022) -
A survey of open questions in adaptive therapy: Bridging mathematics and clinical translation
por: West, Jeffrey, et al.
Publicado: (2023) -
Adaptive therapy for ovarian cancer: An integrated approach to PARP inhibitor scheduling
por: Strobl, Maximilian, et al.
Publicado: (2023) -
Evidence of intermetastatic heterogeneity for pathological response and genetic mutations within colorectal liver metastases following preoperative chemotherapy
por: Sebagh, Mylène, et al.
Publicado: (2016) -
Treatment of evolving cancers will require dynamic decision support
por: Strobl, M. A. R., et al.
Publicado: (2023)